Lemaitre Vasculr Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Lemaitre Vasculr has an operating margin of 23.8%, meaning the company retains $24 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 19.0% the prior year.
Lemaitre Vasculr's revenue grew 13.6% year-over-year to $219.9M, a solid pace of expansion. This earns a growth score of 68/100.
Lemaitre Vasculr carries a low D/E ratio of 0.64, meaning only $0.64 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 88/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 13.14, Lemaitre Vasculr holds $13.14 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Lemaitre Vasculr converts 16.9% of revenue into free cash flow ($37.2M). This strong cash generation earns a score of 85/100.
Lemaitre Vasculr's ROE of 13.1% shows moderate profitability relative to equity, earning a score of 52/100. This is up from 10.1% the prior year.
Lemaitre Vasculr scores 7.45, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.0B) relative to total liabilities ($214.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Lemaitre Vasculr passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Lemaitre Vasculr generates $1.00 in operating cash flow ($44.1M OCF vs $44.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Lemaitre Vasculr earns $254.9 in operating income for every $1 of interest expense ($52.3M vs $205K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
This page shows Lemaitre Vasculr (LMAT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Lemaitre Vasculr generated $219.9M in revenue in fiscal year 2024. This represents an increase of 13.6% from the prior year.
Lemaitre Vasculr's EBITDA was $61.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 34.0% from the prior year.
Lemaitre Vasculr generated $37.2M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 26.0% from the prior year.
Lemaitre Vasculr reported $44.0M in net income in fiscal year 2024. This represents an increase of 46.3% from the prior year.
Lemaitre Vasculr earned $1.93 per diluted share (EPS) in fiscal year 2024. This represents an increase of 44.0% from the prior year.
Lemaitre Vasculr held $25.6M in cash against $0 in long-term debt as of fiscal year 2024.
Lemaitre Vasculr paid $0.64 per share in dividends in fiscal year 2024. This represents an increase of 14.3% from the prior year.
Lemaitre Vasculr's gross margin was 68.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 3.0 percentage points from the prior year.
Lemaitre Vasculr's operating margin was 23.8% in fiscal year 2024, reflecting core business profitability. This is up 4.8 percentage points from the prior year.
Lemaitre Vasculr's net profit margin was 20.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 4.5 percentage points from the prior year.
Lemaitre Vasculr's ROE was 13.1% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 2.9 percentage points from the prior year.
Lemaitre Vasculr invested $15.7M in research and development in fiscal year 2024. This represents a decrease of 7.8% from the prior year.
Lemaitre Vasculr spent $1.7M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 101.5% from the prior year.
Lemaitre Vasculr invested $7.0M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 4.2% from the prior year.
LMAT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $61.0M-5.0% | $64.2M+7.3% | $59.9M+7.5% | $55.7M-0.2% | $55.8M+4.4% | $53.5M+9.4% | $48.9M+3.1% | $47.4M |
| Cost of Revenue | $15.1M-21.6% | $19.3M+4.4% | $18.5M+7.7% | $17.1M-1.5% | $17.4M+3.4% | $16.8M+7.7% | $15.6M-5.9% | $16.6M |
| Gross Profit | $46.0M+2.2% | $45.0M+8.6% | $41.4M+7.3% | $38.6M+0.3% | $38.5M+4.9% | $36.7M+10.2% | $33.3M+8.0% | $30.8M |
| R&D Expenses | $3.0M-16.1% | $3.5M-13.5% | $4.1M+13.2% | $3.6M-15.5% | $4.3M+4.7% | $4.1M-6.0% | $4.4M+3.0% | $4.2M |
| SG&A Expenses | $10.8M+3.4% | $10.4M-0.9% | $10.5M+10.5% | $9.5M+7.6% | $8.8M-2.1% | $9.0M+6.8% | $8.4M+9.1% | $7.7M |
| Operating Income | $20.3M+25.8% | $16.1M+27.8% | $12.6M-1.8% | $12.9M-10.6% | $14.4M+21.1% | $11.9M+16.3% | $10.2M+11.2% | $9.2M |
| Interest Expense | $1.3M-0.2% | $1.3M+0.7% | $1.3M+529.3% | $205K | $0 | $0 | N/A | N/A |
| Income Tax | $5.2M+21.4% | $4.3M+32.8% | $3.2M+13.9% | $2.8M-22.9% | $3.7M+26.5% | $2.9M+2.2% | $2.8M+22.5% | $2.3M |
| Net Income | $17.4M+26.0% | $13.8M+25.1% | $11.0M-1.5% | $11.2M-5.4% | $11.8M+19.6% | $9.9M+16.8% | $8.5M+12.8% | $7.5M |
| EPS (Diluted) | $0.75+25.0% | $0.60+25.0% | $0.480.0% | $0.48-7.7% | $0.52+18.2% | $0.44+15.8% | $0.38+15.2% | $0.33 |
LMAT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $598.1M+3.5% | $577.6M+3.9% | $556.0M+0.8% | $551.8M+52.0% | $363.1M+2.6% | $354.0M+2.1% | $346.8M+3.8% | $334.0M |
| Current Assets | $452.0M+5.1% | $430.1M+5.4% | $408.1M+1.5% | $402.2M+89.0% | $212.8M+4.9% | $203.0M+4.3% | $194.6M+6.8% | $182.2M |
| Cash & Equivalents | $25.5M-6.2% | $27.2M+7.2% | $25.3M-1.1% | $25.6M+15.0% | $22.3M-16.3% | $26.6M+9.6% | $24.3M+34.4% | $18.1M |
| Inventory | $36.3M+8.3% | $33.5M-1.3% | $33.9M-2.2% | $34.7M+0.5% | $34.5M+10.8% | $31.1M+0.1% | $31.1M+9.9% | $28.3M |
| Accounts Receivable | $32.4M-11.3% | $36.5M+4.1% | $35.1M+16.8% | $30.1M-2.5% | $30.8M+1.9% | $30.2M+20.6% | $25.1M+4.9% | $23.9M |
| Goodwill | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M |
| Total Liabilities | $219.1M+2.0% | $214.9M+3.1% | $208.4M-2.8% | $214.5M+392.6% | $43.5M-4.2% | $45.5M-7.0% | $48.9M+7.7% | $45.4M |
| Current Liabilities | $33.3M+8.0% | $30.8M+24.5% | $24.7M-19.2% | $30.6M+20.3% | $25.4M-5.1% | $26.8M-10.3% | $29.9M+2.9% | $29.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $378.9M+4.5% | $362.7M+4.3% | $347.6M+3.0% | $337.3M+5.6% | $319.5M+3.6% | $308.5M+3.6% | $297.9M+3.2% | $288.6M |
| Retained Earnings | $173.7M+8.0% | $160.8M+6.1% | $151.6M+4.5% | $145.1M+11.6% | $130.0M+6.8% | $121.7M+5.5% | $115.4M+4.9% | $110.1M |
LMAT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $28.8M+41.8% | $20.3M+124.5% | $9.0M-40.5% | $15.2M+57.7% | $9.6M+89.8% | $5.1M-52.8% | $10.7M-9.1% | $11.8M |
| Capital Expenditures | $2.3M+70.0% | $1.3M-3.0% | $1.4M-32.3% | $2.0M+8.8% | $1.9M+37.1% | $1.4M+7.1% | $1.3M+21.5% | $1.1M |
| Free Cash Flow | $26.5M+39.8% | $18.9M+147.5% | $7.7M-41.7% | $13.1M+69.6% | $7.7M+109.3% | $3.7M-60.9% | $9.5M-12.1% | $10.8M |
| Investing Cash Flow | -$27.4M-67.9% | -$16.3M-278.4% | -$4.3M+97.5% | -$173.9M-1480.4% | -$11.0M-366.0% | -$2.4M-4.4% | -$2.3M+77.0% | -$9.9M |
| Financing Cash Flow | -$3.0M-6.7% | -$2.8M+47.2% | -$5.2M-103.2% | $164.1M+5817.1% | -$2.9M-7459.0% | $39K+101.5% | -$2.7M+14.0% | -$3.1M |
| Dividends Paid | $4.5M+0.3% | $4.5M+0.1% | $4.5M+25.5% | $3.6M+0.2% | $3.6M+0.1% | $3.6M+15.2% | $3.1M0.0% | $3.1M |
| Share Buybacks | $0-100.0% | $4K-99.3% | $601K-55.6% | $1.4M+19228.6% | $7K-98.0% | $358K-46.3% | $667K+13240.0% | $5K |
LMAT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.3%+5.3pp | 70.0%+0.8pp | 69.2%-0.1pp | 69.3%+0.4pp | 68.9%+0.3pp | 68.6%+0.5pp | 68.0%+3.0pp | 65.0% |
| Operating Margin | 33.3%+8.1pp | 25.1%+4.0pp | 21.1%-2.0pp | 23.1%-2.7pp | 25.8%+3.6pp | 22.2%+1.3pp | 20.9%+1.5pp | 19.4% |
| Net Margin | 28.4%+7.0pp | 21.4%+3.1pp | 18.4%-1.7pp | 20.1%-1.1pp | 21.2%+2.7pp | 18.5%+1.2pp | 17.3%+1.5pp | 15.8% |
| Return on Equity | 4.6%+0.8pp | 3.8%+0.6pp | 3.2%-0.2pp | 3.3%-0.4pp | 3.7%+0.5pp | 3.2%+0.4pp | 2.8%+0.2pp | 2.6% |
| Return on Assets | 2.9%+0.5pp | 2.4%+0.4pp | 2.0%-0.0pp | 2.0%-1.2pp | 3.3%+0.5pp | 2.8%+0.3pp | 2.4%+0.2pp | 2.3% |
| Current Ratio | 13.58-0.4 | 13.96-2.5 | 16.49+3.4 | 13.14+4.8 | 8.36+0.8 | 7.57+1.1 | 6.51+0.2 | 6.28 |
| Debt-to-Equity | 0.58-0.0 | 0.590.0 | 0.60-0.0 | 0.64+0.5 | 0.14-0.0 | 0.15-0.0 | 0.160.0 | 0.16 |
| FCF Margin | 43.4%+13.9pp | 29.5%+16.7pp | 12.8%-10.8pp | 23.6%+9.7pp | 13.9%+6.9pp | 6.9%-12.5pp | 19.4%-3.4pp | 22.7% |
Similar Companies
Frequently Asked Questions
What is Lemaitre Vasculr's annual revenue?
Lemaitre Vasculr (LMAT) reported $219.9M in total revenue for fiscal year 2024. This represents a 13.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Lemaitre Vasculr's revenue growing?
Lemaitre Vasculr (LMAT) revenue grew by 13.6% year-over-year, from $193.5M to $219.9M in fiscal year 2024.
Is Lemaitre Vasculr profitable?
Yes, Lemaitre Vasculr (LMAT) reported a net income of $44.0M in fiscal year 2024, with a net profit margin of 20.0%.
What is Lemaitre Vasculr's earnings per share (EPS)?
Lemaitre Vasculr (LMAT) reported diluted earnings per share of $1.93 for fiscal year 2024. This represents a 44.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Lemaitre Vasculr's EBITDA?
Lemaitre Vasculr (LMAT) had EBITDA of $61.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Lemaitre Vasculr's gross margin?
Lemaitre Vasculr (LMAT) had a gross margin of 68.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Lemaitre Vasculr's operating margin?
Lemaitre Vasculr (LMAT) had an operating margin of 23.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Lemaitre Vasculr's net profit margin?
Lemaitre Vasculr (LMAT) had a net profit margin of 20.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Lemaitre Vasculr pay dividends?
Yes, Lemaitre Vasculr (LMAT) paid $0.64 per share in dividends during fiscal year 2024.
What is Lemaitre Vasculr's return on equity (ROE)?
Lemaitre Vasculr (LMAT) has a return on equity of 13.1% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Lemaitre Vasculr's free cash flow?
Lemaitre Vasculr (LMAT) generated $37.2M in free cash flow during fiscal year 2024. This represents a 26.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Lemaitre Vasculr's operating cash flow?
Lemaitre Vasculr (LMAT) generated $44.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Lemaitre Vasculr's total assets?
Lemaitre Vasculr (LMAT) had $551.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Lemaitre Vasculr's capital expenditures?
Lemaitre Vasculr (LMAT) invested $7.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Lemaitre Vasculr spend on research and development?
Lemaitre Vasculr (LMAT) invested $15.7M in research and development during fiscal year 2024.
Does Lemaitre Vasculr buy back shares?
Yes, Lemaitre Vasculr (LMAT) spent $1.7M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
What is Lemaitre Vasculr's current ratio?
Lemaitre Vasculr (LMAT) had a current ratio of 13.14 as of fiscal year 2024, which is generally considered healthy.
What is Lemaitre Vasculr's debt-to-equity ratio?
Lemaitre Vasculr (LMAT) had a debt-to-equity ratio of 0.64 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Lemaitre Vasculr's return on assets (ROA)?
Lemaitre Vasculr (LMAT) had a return on assets of 8.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Lemaitre Vasculr's Altman Z-Score?
Lemaitre Vasculr (LMAT) has an Altman Z-Score of 7.45, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Lemaitre Vasculr's Piotroski F-Score?
Lemaitre Vasculr (LMAT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Lemaitre Vasculr's earnings high quality?
Lemaitre Vasculr (LMAT) has an earnings quality ratio of 1.00x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Lemaitre Vasculr cover its interest payments?
Lemaitre Vasculr (LMAT) has an interest coverage ratio of 254.9x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Lemaitre Vasculr?
Lemaitre Vasculr (LMAT) scores 82 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.